Villeparisis, France

Adeline Gadzinski


 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2019-2025

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Adeline Gadzinski: Innovator in Molecular Complexes for Vaccination

Introduction

Adeline Gadzinski is a prominent inventor based in Villeparisis, France. She has made significant contributions to the field of molecular complexes, particularly in the context of targeting antigens for vaccination purposes. With a total of 2 patents, her work is paving the way for advancements in immunology.

Latest Patents

Gadzinski's latest patents focus on a molecular complex designed for targeting antigens towards cells. The first patent describes a complex that includes at least one antigen associated with two ligands of surface molecules. This complex features a first ligand of a sulphated sugar from the glycosaminoglycan family and a second ligand of a specific surface molecule. The first ligand is covalently bonded with the antigen and/or the second ligand. This innovative approach aims to enhance the efficacy of vaccinations by improving the targeting of antigens.

Career Highlights

Throughout her career, Adeline Gadzinski has worked with esteemed organizations such as the Commissariat à l'Énergie Atomique et aux Énergies Alternatives and the Commissariat à l'Énergie Atomique. Her experience in these institutions has allowed her to develop her expertise in molecular biology and vaccine development.

Collaborations

Gadzinski has collaborated with notable colleagues, including Michel Leonetti and Alexandra Savatier. These partnerships have contributed to her research and the successful development of her patents.

Conclusion

Adeline Gadzinski's innovative work in molecular complexes for vaccination represents a significant advancement in the field of immunology. Her contributions are likely to have a lasting impact on vaccine development and public health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…